BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 16501087)

  • 21. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice.
    Rossi SL; Guerbois M; Gorchakov R; Plante KS; Forrester NL; Weaver SC
    Virology; 2013 Mar; 437(2):81-8. PubMed ID: 23351391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge.
    Tretyakova I; Plante KS; Rossi SL; Lawrence WS; Peel JE; Gudjohnsen S; Wang E; Mirchandani D; Tibbens A; Lamichhane TN; Lukashevich IS; Comer JE; Weaver SC; Pushko P
    Vaccine; 2020 Apr; 38(17):3378-3386. PubMed ID: 32085953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG used as an adjuvant for an adenovirus-based Venezuelan equine encephalitis virus vaccine increases the immune response to the vector, but not to the transgene product.
    Perkins SD; Williams AJ; O'Brien LM; Laws TR; Phillpotts RJ
    Viral Immunol; 2008 Dec; 21(4):451-7. PubMed ID: 19115934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity to airborne challenge with Venezuelan equine encephalitis virus develops rapidly after immunization with the attenuated vaccine strain TC-83.
    Phillpotts RJ
    Vaccine; 1999 May; 17(19):2429-35. PubMed ID: 10392625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.
    Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I
    J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of neurovirulence and biodistribution of Venezuelan equine encephalitis replicon particles expressing herpes simplex virus type 2 glycoprotein D.
    Kowalski J; Adkins K; Gangolli S; Ren J; Arendt H; DeStefano J; Obregon J; Tummolo D; Natuk RJ; Brown TP; Parks CL; Udem SA; Long D
    Vaccine; 2007 Mar; 25(12):2296-305. PubMed ID: 17239997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood.
    Erwin-Cohen RA; Porter AI; Pittman PR; Rossi CA; DaSilva L
    Hum Vaccin Immunother; 2017 Jan; 13(1):169-179. PubMed ID: 27870591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection.
    O'Brien L; Perkins S; Williams A; Eastaugh L; Phelps A; Wu J; Phillpotts R
    J Gen Virol; 2009 Apr; 90(Pt 4):874-882. PubMed ID: 19264673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates.
    Pratt WD; Gibbs P; Pitt ML; Schmaljohn AL
    Vaccine; 1998; 16(9-10):1056-64. PubMed ID: 9682359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.
    Dupuy LC; Richards MJ; Ellefsen B; Chau L; Luxembourg A; Hannaman D; Livingston BD; Schmaljohn CS
    Clin Vaccine Immunol; 2011 May; 18(5):707-16. PubMed ID: 21450977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRES-Containing VEEV Vaccine Protects Cynomolgus Macaques from IE Venezuelan Equine Encephalitis Virus Aerosol Challenge.
    Rossi SL; Russell-Lodrigue KE; Killeen SZ; Wang E; Leal G; Bergren NA; Vinet-Oliphant H; Weaver SC; Roy CJ
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003797. PubMed ID: 26020513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The protective activity of the attenuated strain 15 of the Venezuelan equine encephalomyelitis virus in rodent infection via the respiratory tract].
    Filatenkov AG; Khaltaeva GG; Khlebnikova NN; Gorban' SG; Shkurnikova NN; Khamitova MF
    Vopr Virusol; 1991; 36(3):229-31. PubMed ID: 1891877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge.
    Henning L; Endt K; Steigerwald R; Anderson M; Volkmann A
    Front Immunol; 2020; 11():598847. PubMed ID: 33542715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
    Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
    Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
    Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.